
Short answer: for some of my clients, yes. Daxxify's clinical trials reported a median duration around six months, close to double the standard three-month tox cycle. In my chair I tell people to plan on three to five months, with a fair number running longer. Dose and metabolism move that number more than anything else.
Daxxify (daxibotulinumtoxinA) is the newest FDA-approved neurotoxin on the market. It got attention because of its trial numbers. In the pivotal SAKURA studies, the median time until frown lines returned to baseline was around 24 weeks, and a portion of participants still had visible results at six months. That's where the "six-month tox" headline comes from.
Daxxify is stabilized with a peptide instead of the human or animal proteins older toxins use. That peptide carries a positive charge and appears to help the toxin bind more efficiently at the nerve ending. That's the leading explanation for the extended wear, not a promise written into every vial.
I see it land with clients who already know they love their result and want fewer trips to the studio. It also suits anyone whose drive from Lafayette, Youngsville or Broussard makes quarterly visits a hassle. Event planners like it too. One fall visit can carry you from tailgate season through Mardi Gras.
I stock both Daxxify and Xeomin in Maurice, and I'll tell you plainly which one fits. Read about anti-wrinkle injections or take the tox quiz.
Book a consult in Maurice, 15 minutes from Lafayette, and get a mapped answer with the total attached.